Bruce A Reitz
Publication Details
-
Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
Ann Thorac Surg. 2006; (1): 286-91; discussion 291
Heart-lung transplant recipients, when compared with heart transplant recipients, are relatively spared from allograft coronary artery disease. This study was undertaken to investigate whether heart-lung transplant recipients are also spared from experiencing bronchiolitis obliterans syndrome (BOS) when compared with double-lung transplant recipients. In addition, the risk factors for developing BOS after lung transplantation were analyzed.
Help